1161361-88-1

Basic information

• Product Name: 3-methoxy-4-(2-methylpyridin-4-yl)aniline
• Synonyms: 3-methoxy-4-(2-methylpyridin-4-yl)aniline
• CAS NO: 1161361-88-1
• Molecular Weight: 214.267
• Mol File: 1161361-88-1.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 322.3±37.0 °C(Predicted)
• Density: 1.124±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 3-methoxy-4-(2-methylpyridin-4-yl)aniline(CAS DataBase Reference)
• NIST Chemistry Reference: 3-methoxy-4-(2-methylpyridin-4-yl)aniline(1161361-88-1)
• EPA Substance Registry System: 3-methoxy-4-(2-methylpyridin-4-yl)aniline(1161361-88-1)

Safety Data

• Hazardous Substances Data: 1161361-88-1(Hazardous Substances Data)

Upstream product

• 1195173-74-0 4-(2-methoxy-4-nitrophenyl)-2-methylpyridine 
• 3678-63-5 4-chIoro-2-methylpyridine 
• 22282-99-1 4-bromo-2-methylpyridine 
• 660867-80-1 2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine 
• 77337-82-7 1-bromo-2-methoxy-4-nitrobenzene 
• 1009-36-5 2-chloro-5-nitroanisole 

Relevant articles and documents

FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF

The present disclosure relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.

FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF

The present disclosure relates to Fused Morpholinopyrimidines, pharmaceutical compositions comprising an effective amount of a Fused Morpholinopyrimidine and methods for using a Fused Morpholinopyrimidine in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of a Fused Morpholinopyrimidine.

NOVEL SUBSTITUTED BICYCLIC TRIAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS

The present invention is concerned with novel substituted bicyclic triazole derivatives of Formula (I) wherein Het1, R1, R2, A1, A2, A3, A4, L1, and L2 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.